{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:18:10Z","timestamp":1781284690024,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD), and renal tubular cell dysfunction contributes to the pathogenesis of DN. Soluble epoxide hydrolase (sEH) is an enzyme that can hydrolyze epoxyeicosatrienoic acids (EETs) and other epoxy fatty acids (EpFAs) into the less biologically active metabolites. Inhibition of sEH has multiple beneficial effects on renal function, however, the exact role of sEH in hyperglycemia-induced dysfunction of tubular cells is still not fully elucidated. In the present study, we showed that human proximal tubular epithelial (HK-2) cells revealed an upregulation of sEH expression accompanied by the impairment of autophagic flux, mitochondrial dysfunction, ubiquitinated protein accumulation and enhanced endoplasmic reticulum (ER) stress after high glucose (HG) treatment. Furthermore, dysfunctional mitochondria accumulated in the cytoplasm, which resulted in excessive reactive oxygen species (ROS) generation, Bax translocation, cytochrome c release, and apoptosis. However, <jats:italic>t<\/jats:italic>-AUCB, an inhibitor of sEH, partially reversed these negative outcomes. Moreover, we also observed increased sEH expression, impaired autophagy flux, mitochondrial dysfunction and enhanced ER stress in the renal proximal tubular cells of db\/db diabetic mice. Notably, inhibition of sEH by treatment with <jats:italic>t<\/jats:italic>-AUCB attenuated renal injury and partially restored autophagic flux, improved mitochondrial function, and reduced ROS generation and ER stress in the kidneys of db\/db mice. Taken together, these results suggest that inhibition of sEH by <jats:italic>t<\/jats:italic>-AUCB plays a protective role in hyperglycemia-induced proximal tubular injury and that the potential mechanism of <jats:italic>t<\/jats:italic>-AUCB-mediated protective autophagy is involved in modulating mitochondrial function and ER stress. Thus, we provide new evidence linking sEH to the autophagic response during proximal tubular injury in the pathogenesis of DN and suggest that inhibition of sEH can be considered a potential therapeutic strategy for the amelioration of DN.<\/jats:p>","DOI":"10.1038\/s41419-020-2594-x","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T10:03:14Z","timestamp":1590055394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy"],"prefix":"10.1038","volume":"11","author":[{"given":"Xu-shun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-gang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"2594_CR1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4997\/JRCPE.2013.413","volume":"43","author":"G Chan","year":"2013","unstructured":"Chan, G. & Tang, S. C. Current practices in the management of diabetic nephropathy. J. R. Coll. Physicians Edinb. 43, 330\u2013332 (2013). quiz 333.","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"2594_CR2","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1053\/ajkd.2003.50077","volume":"41","author":"R Kikkawa","year":"2003","unstructured":"Kikkawa, R., Koya, D. & Haneda, M. Progression of diabetic nephropathy. Am. J. Kidney Dis. 41, S19\u2013S21 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"2594_CR3","doi-asserted-by":"publisher","first-page":"R1009","DOI":"10.1152\/ajpregu.00809.2010","volume":"300","author":"V Vallon","year":"2011","unstructured":"Vallon, V. The proximal tubule in the pathophysiology of the diabetic kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R1009\u2013R1022 (2011).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2594_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.ackd.2005.01.008","volume":"12","author":"MC Thomas","year":"2005","unstructured":"Thomas, M. C., Burns, W. C. & Cooper, M. E. Tubular changes in early diabetic nephropathy. Adv. Chronic Kidney Dis. 12, 177\u2013186 (2005).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"2594_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He, C. & Klionsky, D. J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67\u201393 (2009).","journal-title":"Annu. Rev. Genet."},{"key":"2594_CR6","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1161\/CIRCRESAHA.117.311082","volume":"120","author":"JM Bravo-San Pedro","year":"2017","unstructured":"Bravo-San Pedro, J. M., Kroemer, G. & Galluzzi, L. Autophagy and mitophagy in cardiovascular disease. Circ. Res. 120, 1812\u20131824 (2017).","journal-title":"Circ. Res."},{"key":"2594_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.neurobiolaging.2013.11.019","volume":"35","author":"CC Tan","year":"2014","unstructured":"Tan, C. C. et al. Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy. Neurobiol. Aging 35, 941\u2013957 (2014).","journal-title":"Neurobiol. Aging"},{"key":"2594_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bcp.2017.11.021","volume":"147","author":"P Bhat","year":"2018","unstructured":"Bhat, P. et al. Modulating autophagy in cancer therapy: advancements and challenges for cancer cell death sensitization. Biochem. Pharmacol. 147, 170\u2013182 (2018).","journal-title":"Biochem. Pharmacol."},{"key":"2594_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nri.2016.100","volume":"16","author":"K Cadwell","year":"2016","unstructured":"Cadwell, K. Crosstalk between autophagy and inflammatory signalling pathways: balancing defence and homeostasis. Nat. Rev. Immunol. 16, 661\u2013675 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2594_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.kint.2015.11.021","volume":"89","author":"GP Kaushal","year":"2016","unstructured":"Kaushal, G. P. & Shah, S. V. Autophagy in acute kidney injury. Kidney Int. 89, 779\u2013791 (2016).","journal-title":"Kidney Int."},{"key":"2594_CR11","doi-asserted-by":"publisher","first-page":"25154","DOI":"10.3390\/ijms161025154","volume":"16","author":"L Wang","year":"2015","unstructured":"Wang, L. & Law, H. K. The role of autophagy in lupus nephritis. Int. J. Mol. Sci. 16, 25154\u201325167 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"2594_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/hmg\/ddx045","volume":"26","author":"P Zhu","year":"2017","unstructured":"Zhu, P., Sieben, C. J., Xu, X., Harris, P. C. & Lin, X. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model. Hum. Mol. Genet. 26, 158\u2013172 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"2594_CR13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00018-017-2639-1","volume":"75","author":"D Yang","year":"2018","unstructured":"Yang, D. et al. Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential. Cell. Mol. Life Sci. 75, 669\u2013688 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"2594_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4093\/dmj.2015.39.6.451","volume":"39","author":"S Kume","year":"2015","unstructured":"Kume, S. & Koya, D. Autophagy: a novel therapeutic target for diabetic nephropathy. Diabetes Metab. J. 39, 451\u2013460 (2015).","journal-title":"Diabetes Metab. J."},{"key":"2594_CR15","doi-asserted-by":"publisher","first-page":"19223","DOI":"10.1002\/jcp.28712","volume":"234","author":"S Saxena","year":"2019","unstructured":"Saxena, S., Mathur, A. & Kakkar, P. Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy. J. Cell. Physiol. 234, 19223\u201319236 (2019).","journal-title":"J. Cell. Physiol."},{"key":"2594_CR16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrneph.2017.129","volume":"13","author":"AV Cybulsky","year":"2017","unstructured":"Cybulsky, A. V. Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases. Nat. Rev. Nephrol. 13, 681\u2013696 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"2594_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","volume":"53","author":"C Morisseau","year":"2013","unstructured":"Morisseau, C. & Hammock, B. D. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu. Rev. Pharm. Toxicol. 53, 37\u201358 (2013).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"2594_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","volume":"87","author":"Z Yu","year":"2000","unstructured":"Yu, Z. et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ. Res. 87, 992\u2013998 (2000).","journal-title":"Circ. Res."},{"key":"2594_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/002215540405200403","volume":"52","author":"AE Enayetallah","year":"2004","unstructured":"Enayetallah, A. E., French, R. A., Thibodeau, M. S. & Grant, D. F. Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues. J. Histochem. Cytochem. 52, 447\u2013454 (2004).","journal-title":"J. Histochem. Cytochem."},{"key":"2594_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","volume":"180","author":"KM Wagner","year":"2017","unstructured":"Wagner, K. M., McReynolds, C. B., Schmidt, W. K. & Hammock, B. D. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases. Pharmacol. Ther. 180, 62\u201376 (2017).","journal-title":"Pharmacol. Ther."},{"key":"2594_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1517\/17460441.2014.881354","volume":"9","author":"T Duflot","year":"2014","unstructured":"Duflot, T., Roche, C., Lamoureux, F., Guerrot, D. & Bellien, J. Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases. Expert Opin. Drug Discov. 9, 229\u2013243 (2014).","journal-title":"Expert Opin. Drug Discov."},{"key":"2594_CR22","volume":"90","author":"X Wang","year":"2019","unstructured":"Wang, X., Li, L., Wang, H., Xiao, F. & Ning, Q. Epoxyeicosatrienoic acids alleviate methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in mice. Scand. J. Immunol. 90, e12791 (2019).","journal-title":"Scand. J. Immunol."},{"key":"2594_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3389\/fphar.2018.01551","volume":"9","author":"JY Liu","year":"2018","unstructured":"Liu, J. Y. Inhibition of soluble epoxide hydrolase for renal health. Front. Pharm. 9, 1551 (2018).","journal-title":"Front. Pharm."},{"key":"2594_CR24","doi-asserted-by":"publisher","first-page":"F971","DOI":"10.1152\/ajprenal.00256.2014","volume":"307","author":"J Kim","year":"2014","unstructured":"Kim, J., Imig, J. D., Yang, J., Hammock, B. D. & Padanilam, B. J. Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation. Am. J. Physiol. Ren. Physiol. 307, F971\u2013F980 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2594_CR25","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1073\/pnas.1815746116","volume":"116","author":"Y Luo","year":"2019","unstructured":"Luo, Y. et al. Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK. Proc. Natl. Acad. Sci. USA 116, 5154\u20135159 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2594_CR26","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/jphp.13113","volume":"71","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol\/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition. J. Pharm. Pharm. 71, 1291\u20131300 (2019).","journal-title":"J. Pharm. Pharm."},{"key":"2594_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.prostaglandins.2017.08.003","volume":"133","author":"B Inceoglu","year":"2017","unstructured":"Inceoglu, B., Bettaieb, A., Haj, F. G., Gomes, A. V. & Hammock, B. D. Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors. Prostaglandins Other Lipid Mediat. 133, 68\u201378 (2017).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"2594_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fncel.2018.00126","volume":"12","author":"HA Bustamante","year":"2018","unstructured":"Bustamante, H. A. et al. Interplay between the autophagy-lysosomal pathway and the ubiquitin-proteasome system: a target for therapeutic development in alzheimer\u2019s disease. Front. Cell Neurosci. 12, 126 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"2594_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/978-3-319-55330-6_28","volume":"982","author":"K Sharma","year":"2017","unstructured":"Sharma, K. Mitochondrial dysfunction in the diabetic kidney. Adv. Exp. Med. Biol. 982, 553\u2013562 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2594_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi, G. & Schwarz, T. L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 20, 31\u201342 (2013).","journal-title":"Cell Death Differ."},{"key":"2594_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cmet.2013.11.005","volume":"18","author":"E Motori","year":"2013","unstructured":"Motori, E. et al. Inflammation-induced alteration of astrocyte mitochondrial dynamics requires autophagy for mitochondrial network maintenance. Cell Metab. 18, 844\u2013859 (2013).","journal-title":"Cell Metab."},{"key":"2594_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/sj.emboj.7601972","volume":"27","author":"T Tatsuta","year":"2008","unstructured":"Tatsuta, T. & Langer, T. Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J. 27, 306\u2013314 (2008).","journal-title":"EMBO J."},{"key":"2594_CR33","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s12035-017-0503-9","volume":"55","author":"AR Anzell","year":"2018","unstructured":"Anzell, A. R., Maizy, R., Przyklenk, K. & Sanderson, T. H. Mitochondrial quality control and disease: insights into ischemia-reperfusion injury. Mol. Neurobiol. 55, 2547\u20132564 (2018).","journal-title":"Mol. Neurobiol."},{"key":"2594_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gde.2014.04.003","volume":"26","author":"JL Schneider","year":"2014","unstructured":"Schneider, J. L. & Cuervo, A. M. Autophagy and human disease: emerging themes. Curr. Opin. Genet. Dev. 26, 16\u201323 (2014).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"2594_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02890439","volume":"61","author":"A Barbosa Junior Ade","year":"1992","unstructured":"Barbosa Junior Ade, A. et al. Inhibition of cellular autophagy in proximal tubular cells of the kidney in streptozotocin-diabetic and uninephrectomized rats. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 61, 359\u2013366 (1992).","journal-title":"Virchows Arch. B Cell Pathol. Incl. Mol. Pathol."},{"key":"2594_CR36","doi-asserted-by":"publisher","first-page":"908185","DOI":"10.1155\/2011\/908185","volume":"2011","author":"M Kitada","year":"2011","unstructured":"Kitada, M. et al. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa\/fa) rats: a model of type 2 diabetes. Exp. Diabetes Res. 2011, 908185 (2011).","journal-title":"Exp. Diabetes Res."},{"key":"2594_CR37","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1681\/ASN.2014050457","volume":"26","author":"M Zhan","year":"2015","unstructured":"Zhan, M., Usman, I. M., Sun, L. & Kanwar, Y. S. Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease. J. Am. Soc. Nephrol. 26, 1304\u20131321 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2594_CR38","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1016\/j.bbagen.2017.07.021","volume":"1861","author":"A Bettaieb","year":"2017","unstructured":"Bettaieb, A. et al. Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia. Biochim. Biophys. Acta Gen. Subj. 1861, 2758\u20132765 (2017).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"2594_CR39","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1681\/ASN.2018100983","volume":"30","author":"S Sakai","year":"2019","unstructured":"Sakai, S. et al. Proximal tubule autophagy differs in type 1 and 2 diabetes. J. Am. Soc. Nephrol. 30, 929\u2013945 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2594_CR40","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3892\/ijmm.2014.2052","volume":"35","author":"X Zhao","year":"2015","unstructured":"Zhao, X. et al. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells. Int. J. Mol. Med. 35, 684\u2013692 (2015).","journal-title":"Int. J. Mol. Med."},{"key":"2594_CR41","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbamcr.2010.08.007","volume":"1813","author":"E Deas","year":"2011","unstructured":"Deas, E., Wood, N. W. & Plun-Favreau, H. Mitophagy and Parkinson\u2019s disease: the PINK1-parkin link. Biochim. Biophys. Acta 1813, 623\u2013633 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"2594_CR42","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1471-4159.2011.07253.x","volume":"117","author":"C Meissner","year":"2011","unstructured":"Meissner, C., Lorenz, H., Weihofen, A., Selkoe, D. J. & Lemberg, M. K. The mitochondrial intramembrane protease PARL cleaves human Pink1 to regulate Pink1 trafficking. J. neurochemistry 117, 856\u2013867 (2011).","journal-title":"J. neurochemistry"},{"key":"2594_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/ncb2012","volume":"12","author":"S Geisler","year":"2010","unstructured":"Geisler, S. et al. PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1. Nat. Cell Biol. 12, 119\u2013131 (2010).","journal-title":"Nat. Cell Biol."},{"key":"2594_CR44","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.febslet.2010.02.016","volume":"584","author":"S Kawajiri","year":"2010","unstructured":"Kawajiri, S. et al. PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy. FEBS Lett. 584, 1073\u20131079 (2010).","journal-title":"FEBS Lett."},{"issue":"10","key":"2594_CR45","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1111\/acer.13847","volume":"42","author":"Chi Zhou","year":"2018","unstructured":"Zhou, C. et al. Pharmacological inhibition of soluble epoxide hydrolase ameliorates chronic ethanol-induced cardiac fibrosis by restoring autophagic flux. Alcohol Clin. Exp. Res. 42, 1970\u20131978 (2018).","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"2594_CR46","doi-asserted-by":"publisher","first-page":"14189","DOI":"10.1074\/jbc.M113.458414","volume":"288","author":"A Bettaieb","year":"2013","unstructured":"Bettaieb, A. et al. Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue. J. Biol. Chem. 288, 14189\u201314199 (2013).","journal-title":"J. Biol. Chem."},{"key":"2594_CR47","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1111\/febs.14100","volume":"284","author":"A Bettaieb","year":"2017","unstructured":"Bettaieb, A. et al. Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury. FEBS J. 284, 1970\u20131986 (2017).","journal-title":"FEBS J."},{"key":"2594_CR48","doi-asserted-by":"publisher","first-page":"F915","DOI":"10.1152\/ajprenal.00534.2017","volume":"315","author":"Q Wang","year":"2018","unstructured":"Wang, Q. et al. Expression of soluble epoxide hydrolase in renal tubular epithelial cells regulates macrophage infiltration and polarization in IgA nephropathy. Am. J. Physiol. Ren. Physiol. 315, F915\u2013f926 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"2594_CR49","doi-asserted-by":"publisher","first-page":"R1307","DOI":"10.1152\/ajpregu.00759.2010","volume":"301","author":"AA Elmarakby","year":"2011","unstructured":"Elmarakby, A. A. et al. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R1307\u2013R1317 (2011).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"2594_CR50","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2133\/dmpk.24.438","volume":"24","author":"A Oguro","year":"2009","unstructured":"Oguro, A., Fujita, N. & Imaoka, S. Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression. Drug Metab. Pharmacokinet. 24, 438\u2013445 (2009).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"2594_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1073\/pnas.1422590112","volume":"112","author":"C Lopez-Vicario","year":"2015","unstructured":"Lopez-Vicario, C. et al. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides. Proc. Natl. Acad. Sci. USA 112, 536\u2013541 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2594_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0842-y","volume":"17","author":"Y Fan","year":"2017","unstructured":"Fan, Y., Lee, K., Wang, N. & He, J. C. The role of endoplasmic reticulum stress in diabetic nephropathy. Curr. Diabetes Rep. 17, 17 (2017).","journal-title":"Curr. Diabetes Rep."},{"key":"2594_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.taap.2015.03.022","volume":"286","author":"TR Harris","year":"2015","unstructured":"Harris, T. R. et al. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice. Toxicol. Appl. Pharm. 286, 102\u2013111 (2015).","journal-title":"Toxicol. Appl. Pharm."},{"key":"2594_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011979","volume":"5","author":"O Jung","year":"2010","unstructured":"Jung, O. et al. Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease. PLoS ONE 5, e11979 (2010).","journal-title":"PLoS ONE"},{"key":"2594_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep42764","volume":"7","author":"XS Jiang","year":"2017","unstructured":"Jiang, X. S. et al. Autophagy protects against palmitic acid-induced apoptosis in podocytes in vitro. Sci. Rep. 7, 42764 (2017).","journal-title":"Sci. Rep."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2594-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:56:28Z","timestamp":1670252188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2594-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2594-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"385"}}